Single treatment with the mitochondria-targeted Kv1.3 inhibitors PCARBTP or PAPTP, respectively, efficiently killed human multiple myeloma cells lines with EC50 ranging between 0.1 and 0.9 μM depending on cell line and inhibitor (Figure 1b). The gene discussed is KCNA3; the disease is plasma cell myeloma.